- Home
- TXMD vs WAL Comparison
TXMD vs WAL Comparison
Compare TXMD & WAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- WAL
- Stock Information
- Founded
- TXMD 2008
- WAL 1994
- Country
- TXMD United States
- WAL United States
- Employees
- TXMD N/A
- WAL N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- WAL Major Banks
- Sector
- TXMD Health Care
- WAL Finance
- Exchange
- TXMD Nasdaq
- WAL Nasdaq
- Market Cap
- TXMD 12.8M
- WAL 8.3B
- IPO Year
- TXMD N/A
- WAL 2005
- Fundamental
- Price
- TXMD $1.13
- WAL $81.03
- Analyst Decision
- TXMD
- WAL Strong Buy
- Analyst Count
- TXMD 0
- WAL 15
- Target Price
- TXMD N/A
- WAL $95.13
- AVG Volume (30 Days)
- TXMD 60.3K
- WAL 733.7K
- Earning Date
- TXMD 08-11-2025
- WAL 07-17-2025
- Dividend Yield
- TXMD N/A
- WAL 1.87%
- EPS Growth
- TXMD N/A
- WAL 6.13
- EPS
- TXMD N/A
- WAL 7.28
- Revenue
- TXMD $1,841,000.00
- WAL $3,049,400,000.00
- Revenue This Year
- TXMD $427.09
- WAL $13.22
- Revenue Next Year
- TXMD N/A
- WAL $9.81
- P/E Ratio
- TXMD N/A
- WAL $11.18
- Revenue Growth
- TXMD 53.55
- WAL 11.37
- 52 Week Low
- TXMD $0.70
- WAL $57.05
- 52 Week High
- TXMD $2.44
- WAL $98.10
- Technical
- Relative Strength Index (RSI)
- TXMD 44.02
- WAL 68.54
- Support Level
- TXMD $1.07
- WAL $75.00
- Resistance Level
- TXMD $1.21
- WAL $77.23
- Average True Range (ATR)
- TXMD 0.09
- WAL 2.12
- MACD
- TXMD 0.00
- WAL 0.75
- Stochastic Oscillator
- TXMD 54.68
- WAL 83.00
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About WAL Western Alliance Bancorporation (DE)
Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.